# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Cardiomyopathy

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 277 results.
Bromocriptine in the Treatment of Peripartum Cardiomyopathy
Status: Recruiting
Last Changed: Sep 06, 2017
First Received: Oct 29, 2015
Disease(s): Peripartum Cardiomyopathy
Intervention(s): Bromocriptine, Guideline-driven medical therapy (GDMT)
Locations: Montreal Heart Institute, Monteal, Quebec, Canada
Edema and Fibrosis CMR Imaging in Cardiomyopathy
Status: Recruiting
Last Changed: Jun 25, 2020
First Received: May 23, 2018
Disease(s): Cardiomyopathies
Intervention(s): 7 T CMR
Locations: University of Pennsylvania, Philadelphia, Pennsylvania, United States
Analysis of Cardiac Biomarkers, ECG and CPET Results in Children With Cardiomyopathies
Status: Not yet recruiting
Last Changed: Mar 20, 2020
First Received: Mar 20, 2020
Disease(s): Cardiomyopathies
Intervention(s): ECG, 24-hour ECG monitoring, Cardio-pulmonary exercise test (CPET), Cardiac biomarkers
Study of Efficacy of Oral Sacubitril/Valsartan in Adult Patients With Non-obstructive Hypertrophic Cardiomyopathy
Status: Recruiting
Last Changed: Aug 05, 2020
First Received: Nov 15, 2019
Disease(s): Cardiomyopathy, Hypertrophic
Intervention(s): LCZ696, Placebo
Locations: Novartis Investigative Site, Boston, Massachusetts, United States
Novartis Investigative Site, Morristown, New Jersey, United States
Novartis Investigative Site, Berlin, Germany
Novartis Investigative Site, Berlin, Germany
Novartis Investigative Site, Kiel, Germany
... and 4 other locations.
Evaluation of Alpha-Lipoic Acid in Diabetic Cardiomyopathy
Status: Not yet recruiting
Last Changed: Oct 28, 2019
First Received: Oct 28, 2019
Disease(s): Diabetic Cardiomyopathies
Intervention(s): Physiomance acide lipoïque gold, Placebo - Physiomance acide lipoïque gold
Locations: Nice Hospital, Nice, France
Will Elevated Left Ventricle Filling Pressures Decrease by a Group Exercise Program in Patients With Hypertrophic CardioMyopathy?
Status: Recruiting
Last Changed: Oct 09, 2018
First Received: May 25, 2018
Disease(s): Hypertrophic Cardiomyopathy
Intervention(s): Exercise training
Locations: Rigshospitalet, Copenhagen, Denmark
Arrhythmogenic Substrate in Primary Cardiomyopathies
Status: Recruiting
Last Changed: Mar 26, 2020
First Received: Oct 09, 2017
Disease(s): Primary Cardiomyopathy
Intervention(s): ablation
Locations: IRCCS Policlinico S. Donato, San Donato Milanese, Milano, Italy
Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy
Status: Recruiting
Last Changed: Oct 16, 2019
First Received: Sep 10, 2019
Disease(s): Diabetic Cardiomyopathies
Intervention(s): AT-001, Placebo
Locations: Mountain View Clinical Research, Greer, South Carolina, United States
Juno Research, LLC - Northwest Site, Houston, Texas, United States
Juno Research, LLC - Southwest Houston Site, Houston, Texas, United States
Juno Research, LLC - Katy, Katy, Texas, United States
Effects of Renal Transplantation on Uraemic Cardiomyopathy
Status: Recruiting
Last Changed: Mar 27, 2019
First Received: Mar 27, 2019
Disease(s): Cardiomyopathies
Intervention(s): Cardiac MRI
Locations: Queen Elizabeth Hospital, Birmingham, West Midlands, United Kingdom
Optimisation of Decision Making for Defibrillator Implantation in Hypertrophic Cardiomyopathy
Status: Not yet recruiting
Last Changed: Apr 17, 2019
First Received: Feb 19, 2019
Disease(s): Hypertrophic Cardiomyopathy
Locations: Centre de référence pour les cardiomyopathies et les troubles du rythme héréditaires ou rares - UF de Génétique, Hôpital Ambroise Paré,, Boulogne Billancourt, Hauts-de-Seine, France